Polyunsaturated fatty acid suppression of fatty acid synthase (FASN): evidence for dietary modulation of NF-Y binding to the Fasn promoter by SREBP-1c
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Dietary PUFAs (polyunsaturated fatty acids) co-ordinately suppress transcription of a group of hepatic genes encoding glycolytic and lipogenic enzymes. Suppression of Fasn (fatty acid synthase) transcription involves two PUFA-responsive regions, but the majority of PUFA sensitivity maps to a region within the proximal promoter containing binding sites for NF-Y (nuclear factor-Y), Sp1 (stimulatory protein 1), SREBP (sterol-regulatory-elementbinding protein), and USF (upstream stimulatory factor). Promoter activation assays indicate that altered NF-Y is the key component in regulation of Fasn promoter activity by PUFA. Using electrophoretic mobility-shift assay and chromatin immunoprecipitation analysis, we demonstrate for the first time that PUFAs decrease in vivo binding of NF-Y and SREBP-1c to the proximal promoter of the hepatic Fasn gene and the promoters of three additional genes, spot 14, stearoyl-CoA desaturase and farnesyl diphosphate synthase that are also down-regulated by PUFA. The comparable 50% decrease in NF-Y and SREBP-1c binding to the promoters of the respective PUFA-sensitive genes occurred despite no change in nuclear NF-Y content and a 4-fold decrease in SREBP-1c. Together, these findings support a mechanism whereby PUFA reciprocally regulates the binding of NF-Y and SREBP-1c to a subset of genes which share similar contiguous arrangements of sterol regulatory elements and NF-Y response elements within their promoters. PUFA-dependent regulation of SREBP-1c and NF-Y binding to this unique configuration of response elements may represent a nutrient-sensitive motif through which PUFA selectively and co-ordinately targets subsets of hepatic genes involved in lipid metabolism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In line with this finding, a study showed that dietary polyunsaturated FAs coordinately suppressed transcription of a group of hepatic genes, with a 4-fold decrease in SREBP1c protein in hepatic nuclear protein extracts [88].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [88]
Citations
Cites
The Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular Analysis
McGarry, J. D., & Brown, N. F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00001.x · Cited by 1,616
Regulation of sterol regulatory element binding proteins in livers of fasted and refed mice
Horton, J. D., Bashmakov, Y., Shimomura, I., & Shimano, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5987 · Cited by 577
Osborne, T. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000017200 · Cited by 521
Xu, J., Nakamura, M. T., Cho, H. P., & Clarke, S. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23577 · Cited by 499
Self-citationBrandt, J. M., Djouadi, F., & Kelly, D. P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23786 · Cited by 456
Unsaturated Fatty Acids Down-regulate SREBP Isoforms 1a and 1c by Two Mechanisms in HEK-293 Cells
Hannah, V. C., Ou, J., Luong, A., Goldstein, J. L., & Brown, M. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007273200 · Cited by 448
Kim, H.-J., Takahashi, M., & Ezaki, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25892 · Cited by 377
Yahagi, N., Shimano, H., Hasty, A. H., Amemiya-Kudo, M., Okazaki, H., Tamura, Y., Iizuka, Y., Shionoiri, F., Ohashi, K., Osuga, J.-I., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35840 · Cited by 364
Shimomura, I., Shimano, H., Korn, B. S., Bashmakov, Y., & Horton, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.35299 · Cited by 333
Worgall, T. S., Sturley, S. L., Seo, T., Osborne, T. F., & Deckelbaum, R. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25537 · Cited by 321
Cited by
Health Implications of High Dietary Omega-6 Polyunsaturated Fatty Acids
Patterson, E., Wall, R., Fitzgerald, G. F., Ross, R. P., & Stanton, C. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/539426 · Cited by 883
“biosynthesis [73, 74].”
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
MUSSO, G., GAMBINO, R., & CASSADER, M. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.08.001 · Cited by 681
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Anderson, N., & Borlak, J. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 385
(n-3) Fatty Acids Alleviate Adipose Tissue Inflammation and Insulin Resistance: Mechanistic Insights
Kalupahana, N. S., Claycombe, K. J., & Moustaid-Moussa, N. (2011) · Advances in Nutrition · doi:10.3945/an.111.000505 · Cited by 305
“Moreover, EPA reduces lipogenesis via inhibition of lipogenic transcription factors such as sterol regulatory element-binding protein-1c, nuclear factor-Y (118), and carbohydrate-responsive element-binding protein (119).”
BackgroundMurphy, R. A., Mourtzakis, M., Chu, Q. S. C., Baracos, V. E., Reiman, T., & Mazurak, V. C. (2011) · Cancer · doi:10.1002/cncr.25709 · Cited by 288
Yasutake, K., Nakamuta, M., Shima, Y., Ohyama, A., Masuda, K., Haruta, N., Fujino, T., Aoyagi, Y., Fukuizumi, K., Yoshimoto, T., et al. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802588133 · Cited by 217
Hormonal and nutritional regulation of SCD1 gene expression
Mauvoisin, D., & Mounier, C. (2011) · Biochimie · doi:10.1016/j.biochi.2010.08.001 · Cited by 211
Omega 3 – Omega 6: What is right for the liver?
El-Badry, A. M., Graf, R., & Clavien, P.-A. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.08.005 · Cited by 201
“The availability of NF-Y is crucial for transcription of FAS [27].”
BackgroundThe Lipogenesis Pathway as a Cancer Target
Abramson, H. N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2005805 · Cited by 165
Kuda, O., Jelenik, T., Jilkova, Z., Flachs, P., Rossmeisl, M., Hensler, M., Kazdova, L., Ogston, N., Baranowski, M., Gorski, J., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1305-z · Cited by 142
“The decrease of hepatic triacylglycerol production by DHA/EPA may represent a functional outcome of the coordinated suppression of lipogenic genes by n-3 LC-PUFA [17].”
BackgroundKopecky, J., Rossmeisl, M., Flachs, P., Kuda, O., Brauner, P., Jilkova, Z., Stankova, B., Tvrzicka, E., & Bryhn, M. (2009) · Proceedings of the Nutrition Society · doi:10.1017/s0029665109990231 · Cited by 137
“The hypolipidaemic and anti-obesity effects of n-3 LC PUFA probably depend on the in situ suppression of lipogenesis and increase in fatty acid oxidation in several tissues including liver, intestine, and adipose tissue((12,31,33,34)).”
BackgroundWang, L., Lin, Q., Yang, T., Liang, Y., Nie, Y., Luo, Y., Shen, J., Fu, X., Tang, Y., & Luo, F. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b03230 · Cited by 131
Dietary habits and behaviors associated with nonalcoholic fatty liver disease
Yasutake, K., Kohjima, M., Kotoh, K., Nakashima, M., Nakamuta, M., & Enjoji, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1756 · Cited by 142
Rudolph, M. C., Monks, J., Burns, V., Phistry, M. M., Marians, R. C., Foote, M. R., Bauman, D. E., Anderson, S. M., & Neville, M. C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00376.2010 · Cited by 118
“PUFA have also been shown to repress fatty acid synthase, possibly regulating the binding of SREBF1c and nuclear factor Y through contiguous regions in the promoter (43).”
BackgroundSelective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers
Honma, M., Sawada, S., Ueno, Y., Murakami, K., Yamada, T., Gao, J., Kodama, S., Izumi, T., Takahashi, K., Tsukita, S., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0062-9 · Cited by 108
“Two patients who had been taking eicosapentaenoic acid (EPA) were also excluded from the analysis, because EPA reportedly exerts beneficial effects on hepatic steatosis [18] and steatohepatitis [19] by reducing the expression of sterol responsive element binding protein-1c (SREBP-1c) [20].”
BackgroundLofterød, T., Mortensen, E., Nalwoga, H., Wilsgaard, T., Frydenberg, H., Risberg, T., Eggen, A. E., McTiernan, A., Aziz, S. M., Wist, E. A., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4568-2 · Cited by 107
“observations on HER2+ tumors which suggest a reduced tumor proliferation from the inhibitory effect of polyunsaturated fatty acids on fatty acid synthase [48, 49].”
BackgroundHowell, G., Deng, X., Yellaturu, C., Park, E. A., Wilcox, H. G., Raghow, R., & Elam, M. B. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.08.008 · Cited by 100
“Studies of PUFA repression of transcription in other promoter contexts also identified the NF-Y and SRE binding sites as potential mediators of inhibitory effects of PUFA [28,33].”
Zheng, X., Leaver, M. J., & Tocher, D. R. (2009) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2009.06.010 · Cited by 94
Jelenik, T., Rossmeisl, M., Kuda, O., Jilkova, Z. M., Medrikova, D., Kus, V., Hensler, M., Janovska, P., Miksik, I., Baranowski, M., et al. (2010) · Diabetes · doi:10.2337/db09-1716 · Cited by 88
“Previous animal studies demonstrated that n-3 LC-PUFAs could counteract the development of both hepatic steatosis (8,18,36,37) and hepatic insulin resistance (8,9,16), while suppressing lipogenesis and augmenting lipid catabolism in the liver (8,13,19,21).”
BackgroundTruong, X. T., & Lee, D. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0644 · Cited by 84
“Downregulation occurred at two levels: the expression of SREBP1a and SREBP1c genes were markedly reduced, and the proteolytic processing of these SREBPs was also inhibited [87,88].”
Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease
Eslamparast, T. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v7.i2.204 · Cited by 77
Holth, T. F., Nourizadeh-Lillabadi, R., Blaesbjerg, M., Grung, M., Holbech, H., Petersen, G. I., Aleström, P., & Hylland, K. (2008) · Aquatic Toxicology · doi:10.1016/j.aquatox.2008.08.020 · Cited by 100
Microarray analyses of SREBP-1a and SREBP-1c target genes identify new regulatory pathways in muscle
Rome, S., Lecomte, V., Meugnier, E., Rieusset, J., Debard, C., Euthine, V., Vidal, H., & Lefai, E. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.90211.2008 · Cited by 74
Witkiewicz, A. K., Nguyen, K., Dasgupta, A., Kennedy, E. P., Yeo, C. J., Lisanti, M. P., & Brody, J. R. (2008) · Cell Cycle · doi:10.4161/cc.7.19.6719 · Cited by 71
Prevention and Reversal of Obesity and Glucose Intolerance in Mice by DHA Derivatives
Rossmeisl, M., Jelenik, T., Jilkova, Z., Slamova, K., Kus, V., Hensler, M., Medrikova, D., Povysil, C., Flachs, P., Mohamed‐Ali, V., et al. (2009) · Obesity · doi:10.1038/oby.2008.602 · Cited by 66
“Decreased binding of both sterolregulatory element binding protein–1c and nuclear factor-Y to promoters of lipogenic genes (19), as well as activation of AMPactivated protein kinase (20), may be of great importance for the liver effects.”
BackgroundDietary fat’gene interactions in cancer
Chen, Y. Q., Edwards, I. J., Kridel, S. J., Thornburg, T., & Berquin, I. M. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9075-x · Cited by 75
“In addition, there may be a cross-talk with another type of lipid as evidence suggests that polyunsaturated fatty acids suppress FASN synthesis [35, 36].”
BackgroundTargeting metabolism in breast cancer: How far we can go?
Long, J., Li, X.-N., & Zhang, F. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i1.122 · Cited by 75
Jacobs, A. A. A., Dijkstra, J., Liesman, J. S., VandeHaar, M. J., Lock, A. L., van Vuuren, A. M., Hendriks, W. H., & van Baal, J. (2013) · animal · doi:10.1017/s175173111300061x · Cited by 57
“Alternatively, PUFA may also modulate the interaction of lipogenic transcription factors with the promoter of lipogenic genes directly, as reported for the hepatic FASN gene (Teran-Garcia et al., 2007).”
BackgroundGeay, F., Zambonino‐Infante, J., Reinhardt, R., Kuhl, H., Santigosa, E., Cahu, C. L., & Mazurais, D. (2011) · Marine Genomics · doi:10.1016/j.margen.2011.08.003 · Cited by 50
“In mammals, Sp1 has been shown to contribute with NF-Y transcription factors to the regulation by SREBP of the expression of several genes involved in cholesterogenic and lipogenic pathways (Amemiya-Kudo et al., 2002; Teran-Garcia et al., 2007).”
BackgroundGarcía‐Fuentes, E., Santiago‐Fernández, C., Gutiérrez‐Repiso, C., Mayas, M. D., Oliva‐Olivera, W., Coín‐Aragüez, L., Alcaide, J., Ocaña-Wilhelmi, L., Vendrell, J. J., Tinahones, F. J., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0732-5 · Cited by 52
“We do not know the reason for this discrepancy between the in vivo and in vitro results, but the n-6 polyunsaturated fatty acids could be involved, as they were increased in vivo in morbidly obese subjects [25] down-regulating the SREBP-1c expression [39, 40].”
BackgroundResultAredes, M. A., da Camara, A. O., de Paula, N. S., Fraga, K. Y. D., do Carmo, M. D. G. T., & Chaves, G. V. (2019) · Nutrition · doi:10.1016/j.nut.2019.06.009 · Cited by 71
Román, S., Ojeda-Granados, C., Ramos-Lopez, O., & Panduro, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i12.3449 · Cited by 46
Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming
Yang, D., Sun, L., Li, Z., & Gao, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1498-7_7 · Cited by 43
Fatty Acid Synthase Activity in Tumor Cells
Little, J. L., & Kridel, S. J. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8831-5_7 · Cited by 46
Nutrition Therapy for Liver Diseases Based on the Status of Nutritional Intake
Yasutake, K., Kohjima, M., Nakashima, M., Kotoh, K., Nakamuta, M., & Enjoji, M. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/859697 · Cited by 39
“n3 PUFAs also suppress fatty acid synthesis by controlling SREBP-1c expression negatively and promote fatty acid βoxidation by activating PPARα expression [24, 25].”
BackgroundPavlišová, J., Bardová, K., Staňková, B., TVRZICKÁ, E., Kopecký, J., & Rossmeisl, M. (2015) · Biochimie · doi:10.1016/j.biochi.2015.07.001 · Cited by 43
Hannila, S. S., Siddiq, M. M., Carmel, J., Hou, J.-W., Chaudhry, N., Bradley, P. M. J., Hilaire, M., Richman, E. L., Hart, R., & Filbin, M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5321-12.2013 · Cited by 31
“, 2005), fatty acid synthase (FASN) (Teran-Garcia et al., 2007), and Smad2 promoters: TNF forward, 5 -TGATGCCTGGGTGTCCCCAAC-3 ; TNF reverse, 5 -TGGTGTCCTCGCTGAGTTCTG-3 ; FASN forward, 5 -GGCATC ACCCCACCGACG-3 ; FASN reverse, 5 -GCTCCCTCTAGGCCGC GC-3 ; Smad2 forward, 5 -GGCTTGCTGGACTAACTTGC-3 ; and Smad2 reverse, 5 -AC…”
Park, H., Liu, Y., Kim, H.-S., & Shin, J.-H. (2015) · Nutrition Research · doi:10.1016/j.nutres.2015.10.010 · Cited by 37
“[43] Teran-Garcia M, Adamson Aaron W, Yu G, Rufo C, Suchankova G, Dreesen Thomas D, et al.”
BackgroundBonačić, K., Campoverde, C., Sastre, M., Hachero‐Cruzado, I., Ponce, M., Manchado, M., Estévez, A., Gisbert, E., & Morais, S. (2015) · Aquaculture · doi:10.1016/j.aquaculture.2015.07.009 · Cited by 44
Promising therapies for treatment of nonalcoholic steatohepatitis
Noureddin, M., Zhang, A., & Loomba, R. S. (2016) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2016.1220533 · Cited by 37
“Omega-3 PUFAs influence liver lipid homeostasis through regulation of fat accumulation and elimination via downregulation of sterol regulatory element binding protein-1 (SREBP-1) [107,108] and nuclear factor-Y (NF-Y) transcription factors [109].”
BackgroundGhadge, A. A., Harsulkar, A., Karandikar, M., Pandit, V. A., & Kuvalekar, A. (2016) · Genes & Nutrition · doi:10.1186/s12263-016-0518-4 · Cited by 39
“GAPDH glyceraldehyde-3phosphate dehydrogenase, PPARγ peroxisome proliferator-activated receptors γ, SREBP1 sterol regulatory element-binding protein, NFκβ nuclear factor kappa β, FAS fatty acid synthase, ACSL long chain acyl CoA synthetases, MCAT malonyl-CoA-acyl carrier protein transacylase, TNFα tumor necrosis facto…”
BackgroundInfluentialUriho, A., Yang, S., Tang, X., Liu, C.-S., Wang, S., Yang, C., Zhang, J., & Zhou, P. (2019) · Food & Function · doi:10.1039/c9fo01353a · Cited by 35
Borges, P., Médale, F., Dias, J. P., & Valente, L. M. P. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512003418 · Cited by 40
“The homogenates were centrifuged at 15 000 g for 20 min at 4 8 C and the activity of FAS was measured on the supernatant.”
InfluentialJacometo, C. B., Schmitt, E., Pfeifer, L. F. M., Schneider, A., Bado, F., da Rosa, F. T., Halfen, S., Pino, F. A. B. D., Loor, J. J., Corrêa, M. N., et al. (2014) · Genes & Nutrition · doi:10.1007/s12263-014-0405-7 · Cited by 35
“Studies demonstrated that a decrease in Srebf1 transcription leads to hepatic inhibition of critical enzyme for lipogenesis (Teran-Garcia et al. 2007), as fatty acid synthase (Fasn) and acetyl-CoA carboxylase alpha (Acaca) (Ronnebaum et al. 2008).”
BackgroundInfluentialZhao, W., Song, F., Hu, D., Chen, H., Zhai, Q., Lu, W., Zhao, J., Zhang, H., Chen, W., Gu, Z., et al. (2020) · Nutrients · doi:10.3390/nu12092507 · Cited by 37
“Fat accumulation caused by lipid metabolism disorder is a common mechanism in hepatic steatosis, followed by immune cell activation and pro-inflammatory cytokine production [3,7].”
BackgroundXie, D., Fu, Z., Wang, S., You, C., Monroig, Ó., Tocher, D. R., & Li, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-23668-w · Cited by 34
Damiano, F., Gnoni, G. V., & Siculella, L. (2008) · Biochemical Journal · doi:10.1042/bj20081082 · Cited by 32
The effects of unsaturated fatty acids on lipid metabolism in HepG2 cells
Kohjima, M., Enjoji, M., Higuchi, N., Kato, M., Kotoh, K., Nakashima, M., & Nakamuta, M. (2008) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-008-9144-7 · Cited by 31
Meher, A. P., Joshi, A. A., & Joshi, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090209 · Cited by 31
Oliveira, L. S. D., Souza, L. L., Souza, A. F. P., Cordeiro, A., Kluck, G. E. G., Atella, G. C., Trevenzoli, I. H., & Pazos-Moura, C. C. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600171 · Cited by 26
Minville-Walz, M., Gresti, J., Pichon, L., Bellenger, S., Bellenger, J., Narce, M., & Rialland, M. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0258-2 · Cited by 29
“Moreover, the NF-Y transcription factor has also been reported for its essential role in either the activation by sterol depletion or the inhibition by PUFA of scd1 promoter activity (Tabor et al. 1999; Teran-Garcia et al. 2007).”
BackgroundOmega-6 Fat Supplementation Alters Lipogenic Gene Expression in Bovine Subcutaneous Adipose Tissue
Joseph, S. J., Pratt, S. L., Pavan, E., Rekaya, R., & Duckett, S. K. (2010) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s5831 · Cited by 27
“Teran-Garcia et al (2007)27 has shown PUFA decrease in vivo binding of NF-Y and SREBP-1c to the proximal promoter of hepatic FASN, Spot 14 and SCD.”
BackgroundWu, J., Luo, J., He, Q., Xia, Y., Tian, H., Zhu, L., Li, C., & Loor, J. J. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c01606 · Cited by 26
Romanelli, M. G., Lorenzi, P., Sangalli, A., Diani, E., & Mottes, M. (2008) · Genomics · doi:10.1016/j.ygeno.2008.11.002 · Cited by 24
“Dietary polyunsaturated fatty acids (PUFAs) suppress transcription of hepatic FDPS, actingon lipogenic transcriptional factor SREBP-1c (SREBF1) and modulating NF-Y binding to regulatory elements in the promoter region [21,22].”
BackgroundYuyama, M., & Fujimori, K. (2014) · Biochemical Journal · doi:10.1042/bj20131476 · Cited by 21
Bardová, K., Funda, J., Pohl, R., Čajka, T., Hensler, M., Kuda, O., Janovská, P., Adamcová, K., Irodenko, I., Lenkova, L., et al. (2020) · Nutrients · doi:10.3390/nu12123737 · Cited by 26
“Thus, DNL is inhibited by Omega-3 [57] and stimulated by TZDs ([56]; see above), reflecting probably the differential control via SCD1 [47,59].”
BackgroundRodríguez‐Cruz, M., González, R. S., García, A. M. S., & López‐Alarcón, M. (2011) · Gene · doi:10.1016/j.gene.2011.12.022 · Cited by 22
Zhang, S., Duan, Y., Zhong, L., Liu, H., Wang, M., & Chen, X. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.121911 · Cited by 19
Pinolenic Acid Downregulates Lipid Anabolic Pathway in HepG2 Cells
Lee, A. R., & Han, S. N. (2016) · Lipids · doi:10.1007/s11745-016-4149-6 · Cited by 19
Maternal omega-3 fatty acids and micronutrients modulate fetal lipid metabolism: A review
Khaire, A. A., Kale, A. A., & Joshi, S. (2015) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2015.04.007 · Cited by 21
“result in lower levels of fatty acids, triglycerols and VLDL [71].”
BackgroundGambo, Y., Matsumura, M., & Fujimori, K. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.04.023 · Cited by 21
“, 1986) and polyunsaturated fatty acids (Teran-Garcia et al., 2007).”
Fotschki, B., Opyd, P., Juśkiewicz, J., Wiczkowski, W., & Jurgoński, A. (2020) · Molecules · doi:10.3390/molecules25122921 · Cited by 18
“Dietary PUFAs may suppress hepatic lipogenesis through mechanisms regulated by sterol regulatory element-binding proteins or by the suppression of fatty acid β-oxidation through PPARα [26,27].”
BackgroundSkořepa, P., Sobotka, O., Vaněk, J., Tichá, A., Fortunato, J., Maňák, J., Blaha, V., Horáček, J. M., & Sobotka, L. (2020) · Nutrients · doi:10.3390/nu12051373 · Cited by 16
“Experimental studies on rats showed thatω–3 andω–6 fatty acid supplementation can inhibit de novo lipogenesis [34,35], which is also increased by a fat-free diet [36].”
BackgroundSelma-Gracia, R., Megušar, P., Haros, C. M., & Laparra, J. M. (2021) · Nutrients · doi:10.3390/nu13051537 · Cited by 16
“Carbohydrates and polyunsaturated fatty acids (PUFA) are identified as positive [29] and negative [30], respectively, regulators of FASN transcripts.”
BackgroundTay, S.-S., Kuah, M., & Shu‐Chien, A. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-22157-4 · Cited by 17
Guo, J., Kong, L., Peng, A. F., Long, X. H., Zhou, Y., & Shu, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5897 · Cited by 13
“Previous studies have demonstrated that NF-Y expression is a key component in the regulation of FASN expression by promoter activity in primary hepatocytes (34).”
BackgroundAmirkalali, B., Khoonsari, M., Sohrabi, M., Ajdarkosh, H., Motamed, N., Maadi, M., Nobakht, H., Gholizadeh, E., & Zamani, F. (2021) · Public Health Nutrition · doi:10.1017/s1368980021001762 · Cited by 13
“Inconsistent with the present study, the literature reported that PUFA (both n-6 and n-3 PUFA) can improve fatty liver by reducing liver TNF-α expression, insulin resistance(42,43) and hepatic de novo lipogenesis(44).”
ResultMetabolic and molecular regulation of dietary polyunsaturated fatty acids on prostate cancer
Zhao, H., Pflug, B. R., Lai, X., & Wang, M. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500066 · Cited by 13
“Dietary PUFAs have been shown to suppress de novo synthesis of fatty acids via FASN through inhibition of the sterol regulatory-binding protein 1c [23, 24].”
BackgroundHu, Y., Zai, H., Jiang, W. H., Ou, Z., Yao, Y., & Zhu, Q. (2021) · Mediators of Inflammation · doi:10.1155/2021/5754592 · Cited by 14
“Activation of SREBP-1c causes upregulation of FASN, enhances fatty acid metabolism, and theoretically promotes cancer development [14].”
BackgroundFatty Acid Synthase (FASN): A Patent Review Since 2016-Present
Singh, S., Karthikeyan, C., & Moorthy, N. S. H. N. (2023) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892818666230112170003 · Cited by 14
Overfeeding of Polyunsaturated Versus Saturated Fatty Acids Reduces Ectopic Fat
Bray, G. A., & Krauss, R. M. (2014) · Diabetes · doi:10.2337/db14-0493 · Cited by 11
“Dietary PUFA may suppress hepatic lipogenesis through mechanisms involving transcriptional regulation by SREBP1-c (14) or PPAR-a (15), although the latter effect also would be expected to modulate fatty acid b-oxidation.”
BackgroundNoumi, Y., Kawamura, R., Tabara, Y., Maruyama, K., Takata, Y., Nishida, W., Okamoto, A., Nishimiya, T., Onuma, H., Saito, I., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13500 · Cited by 13
Guan, L., Chung, H. Y., & Chen, Z. (2011) · Journal of Food Biochemistry · doi:10.1111/j.1745-4514.2010.00425.x · Cited by 9
Hypolipidemic constituents from the aerial portion of Sibiraea angustata
Liu, H., Zhang, T., Jiang, P., Zhu, W., Yu, S., Liu, Y., Li, B., & Li, F. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127161 · Cited by 9
Tan, T. C. H., Crawford, D. H., Jaskowski, L. A., Murphy, T. L., Santrampurwala, N., Crane, D. I., Clouston, A. D., Subramaniam, V. N., Anderson, G. J., & Fletcher, L. M. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12155 · Cited by 9
Alzoubi, M. R., & Al-Domi, H. A. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.06.024 · Cited by 11
“EPA reduces lipogenesis via inhibition of lipogenic transcription factors such as sterol regulatory element-binding protein-1c, nuclear factor-Y (Teran-Garcia et al., 2007) Moreover, EPA stimulate fatty acid oxidation via activation of PPARα and AMPK lead to improvements in hepatic insulin…”
BackgroundMotilva, V., Sánchez‐Fidalgo, S., Barranco, M. D., Herrerías, J. M., & de la Lastra, C. A. (2008) · e-SPEN the European e-Journal of Clinical Nutrition and Metabolism · doi:10.1016/j.eclnm.2007.10.003 · Cited by 7
Rajna, A., Brown, L. H., Frangos, S. M., Gonzalez‐Soto, M., Hucik, B., Wang, C., Wright, D. C., & Mutch, D. M. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.108940 · Cited by 7
Campa, D., Hüsing, A., Chang-Claude, J. C., Dostal, L., Boeing, H., Kröger, J., Tjønneland, A. M., Roswall, N., Overvad, K., Dahm, C. C., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.09.029 · Cited by 8
Gender dependent differences in lipid metabolism in individuals with type 2 diabetes mellitus
Ghadge, A. A., Harsulkar, A., Diwan, A. G., & Kuvalekar, A. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00589-y · Cited by 4
Che, L.-Q., Ren, B., Jia, Y., Dong, Y., Wang, Y., Shan, J., & Wang, Y. (2021) · ACS Omega · doi:10.1021/acsomega.0c05470 · Cited by 5
Apraku, A., Huang, X., Yusuf, A., Cornel, A., Ayisi, C. L., & Asiedu, B. (2019) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2019.05.002 · Cited by 9
Wu, J., Luo, J., He, Q., Zhang, F., Shi, C., Zhao, J., Li, C., & Deng, W. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144076 · Cited by 6
Zhi, J., Xu, G., Rubin, C. T., & Hadjiargyrou, M. (2008) · Calcified Tissue International · doi:10.1007/s00223-007-9100-7 · Cited by 4
“It was previously reported that dietary polyunsaturated fatty acids (PUFAs) suppress FAS transcription by decreasing nuclear SREBP-1 content and altering the binding of NF-Y to promoters of PUFAresponse genes [48].”
BackgroundZhang, Y., Su, Z., Jiang, H., Zhao, Y., Gao, F., Cai, K., Fang, S., & Hu, K. (2025) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2025.111084 · Cited by 3
Chahardahcherik, M., Shahriari, A., Asadian, P., & Esmaeilzadeh, S. (2013) · Iranian Journal of Veterinary Medicine · doi:10.22059/ijvm.2013.35061 · Cited by 3
“Omega-3 fatty acids have hypolipidemic (Ian et al., 2005; Teran-Garcia et al., 2007), anti-inflammatory and antioxidant effects and have shown that they could positively affect NAFLD patients (Hao et al., 2010; Vanwerven et al., 2010).”
BackgroundMolecular cloning of a functional Fads2 promoter from Zebrafish
Chung, H. H., & Zulkharnain, A. (2016) · Journal of Biochemistry Microbiology and Biotechnology · doi:10.54987/jobimb.v4i1.280 · Cited by 3
“activated genes require the presence of NF-Y bound to one or more adjacent CCAAT element which is located in close proximity, within 21 bp of the SRE [13-15].”
BackgroundHalas, V., & Babinszky, L. (2010) · Acta Agriculturae Scandinavica Section A – Animal Science · doi:10.1080/09064700903567807 · Cited by 3
“Dietary polyenoic (n-6 and n-3) fatty acids uniquely regulate fatty acid biosynthesis and fatty acid oxidation by modulating the expression of gene coding for key metabolic enzymes (Price et al, 2000 ; Teran-Garcia et al, 2007 ).”
BackgroundSuchner, U. (2026) · Nutrients · doi:10.3390/nu18040626 · Cited by 3
Duan, W., Jiang, N., Wang, Y., Li, X., Liu, C., & Liu, X. (2026) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2026.151573 · Cited by 1
Lipid Mediators in Metabolic Syndrome and Neurological Disorders
Farooqui, A. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7318-3_4 · Cited by 1
de Oliveira, S. C. P., Miyaguti, N. A. D. S., Russell, S. T., Tobar, N., Geraldo, M. V., & Gomes‐Marcondes, M. C. C. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000863 · Cited by 1
Genetic regulation of the healthfulness of beef fatty acid composition
Zhang, S. (2008) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/rtd-180813-16999 · Cited by 2
“…regulation of SREBP1c and NF-Y binding to a unique configuration of their response elements within the promoter of target genes may represent a common mechanism through which dietary PUFA selectively and reciprocally regulates hepatic genes involved in lipid metabolism (Teran-Garcia et al., 2007).”
BackgroundBarsalani, R. (2010) · doi:10.71781/29572 · Cited by 1
Coelho, D. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2013.tde-29052014-161540
Multimodal prehabilitation in lung cancer patients undergoing surgical resection
Ferreira, V. (2021) · eScholarship@McGill (McGill) · doi:10.82308/34245
Serrat, G. O. (2012) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
(2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328303e27e
Zhang, Y., Su, Z., Jiang, H., Zhao, Y., Gao, F., Cai, K., Fang, S., & Hu, K. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5415150
Metadata
- Authors
- Teran-Garcia, M., Adamson, A. W., Yu, G., Rufo, C., Suchankova, G., Dreesen, T. D., Tekle, M., Clarke, S. D., & Gettys, T. W.
- Affiliations
- Department of Adipocyte Signalling, Pennington Biomedical Research Center, Baton Rouge, LA 70808, U.S.A.
- Pennington Biomedical Research Center (US)
- Universidad de la República de Uruguay (UY)
- Diabetes Research Unit, Boston Medical Center, Boston, MA 02118, U.S.A.
- Therapeutic Monitoring Services, New Orleans, LA 70115, U.S.A.
- McNeil Nutritionals, New Brunswick, NJ 08901, U.S.A.
- Corresponding author
- Yu, Gang
- Tekle, Michael
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2007-02-26
- Volume
- 402
- Issue
- 3
- Pages
- 591-600
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- PMC
- PMC1863568
- OpenAlex
- W1995058030
- Cited by
- 104
- References
- 46
- Citations by year
- 2026: 3 · 2025: 5 · 2023: 3 · 2022: 1 · 2021: 6 · 2020: 6 · 2019: 3 · 2018: 4 · 2017: 2 · 2016: 10 · 2015: 7 · 2014: 7 · 2013: 6 · 2012: 4
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK072476)
- National Institute of General Medical Sciences (P30GM118430)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK06156, R01DK053872, T32DK064584, P30DK072476, DK-53872)
- National Center for Research Resources (P20RR021945)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Keywords
- polyunsaturated fatty acids, fatty acid synthase, NF-Y, SREBP-1c, transcriptional regulation, hepatic gene expression, sterol regulatory element, stearoyl-CoA desaturase, farnesyl diphosphate synthase, lipid metabolism, dietary modulation
- MeSH terms
- Animals, Animal Feed, Base Sequence, Cell Nucleus, Cells, Cultured, Fatty Acids, Unsaturated, Male, Molecular Sequence Data, Promoter Regions, Genetic, Protein Binding, Protein Processing, Post-Translational, Transcription, Genetic, Down-Regulation, Sp1 Transcription Factor, Rats, Sprague-Dawley, Hepatocytes, CCAAT-Binding Factor, Electrophoretic Mobility Shift Assay, Rats, Sterol Regulatory Element Binding Protein 1, Fatty Acid Synthases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.